Advertisement
Screener

AIM IMMUNOTECH INC. (AIM) Executive Pay versus Performance: Pay versus Performance

AIM IMMUNOTECH INC. Pay versus Performance

The Pay versus Performance table from each proxy statement (Item 402(v)), as tagged in its XBRL, newest proxy first. Each proxy's own figures are kept, so a year restated in a later proxy appears once per proxy. PEO is the principal executive officer; NEO means the other named executive officers (average). Total shareholder return is the value of a $100 investment.

  • 2024-12-31: PEO Thomas K. Equels; PEO total compensation $1.09M; PEO compensation actually paid $1.07M; Other NEO average total compensation $285.94K.
  • 2023-12-31: PEO Thomas K. Equels; PEO total compensation $1.43M; PEO compensation actually paid $1.46M; Other NEO average total compensation $369.86K.
  • 2022-12-31: PEO Thomas K. Equels; PEO total compensation $1.35M; PEO compensation actually paid $1.24M; Other NEO average total compensation $332.11K.
Fiscal year endPEOPEO total compensationPEO compensation actually paidOther NEO average total compensationOther NEO average compensation actually paidTotal shareholder returnPeer group total shareholder returnNet incomeCompany-selected measureProxy filed
2024-12-31Thomas K. Equels$1.09M$1.07M$285.94K$282.17K$21.52-$17.32M2025-10-29
2023-12-31Thomas K. Equels$1.43M$1.46M$369.86K$375.16K$47.83-$28.96M2025-10-29
2022-12-31Thomas K. Equels$1.35M$1.24M$332.11K$288.86K$33.70-$19.45M2025-10-29

Similar stocks

Stock NameCountryMarket CapPE Ratio
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)United States$0.006B
CERO THERAPEUTICS HOLDINGS, INC. (CERO)United States$0.007B
PharmaCyte Biotech, Inc. (PMCB)United States$0.005B
TScan Therapeutics, Inc. (TCRX)United States$0.008B-1.23
WINDTREE THERAPEUTICS INC /DE/ (WINT)United States$0.003B-0.32
VivoSim Labs, INC. (VIVS)United States$0.003B
Calidi Biotherapeutics, Inc. (CLDI)United States$0.003B
CURIS INC (CRIS)United States$0.002B-0.05
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70
Silexion Therapeutics Corp (SLXN)$0.001B